FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017505770> ?p ?o ?g. }

• W2017505770 endingPage "1881" @default.
• W2017505770 startingPage "1877" @default.
• W2017505770 abstract "No AccessJournal of UrologyAdult Urology1 Nov 2010Percutaneous Biopsy of Primary Tumor in Metastatic Renal Cell Carcinoma to Predict High Risk Pathological Features: Comparison With Nephrectomy Assessment E. Jason Abel, Stephen H. Culp, Surena F. Matin, Pheroze Tamboli, Michael J. Wallace, Eric Jonasch, Nizar M. Tannir, and Christopher G. Wood E. Jason AbelE. Jason Abel Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author , Stephen H. CulpStephen H. Culp Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author , Surena F. MatinSurena F. Matin Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author , Pheroze TamboliPheroze Tamboli Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author , Michael J. WallaceMichael J. Wallace Department of Radiology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author , Eric JonaschEric Jonasch Department of Genitourinary Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author , Nizar M. TannirNizar M. Tannir Department of Genitourinary Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author , and Christopher G. WoodChristopher G. Wood Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.06.105AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: As treatment options evolve for metastatic renal cell carcinoma, there is a need for predictive information to help guide therapy. We assessed the accuracy of percutaneous primary tumor biopsy for metastatic renal cell carcinoma by comparing biopsy findings to final nephrectomy pathology in patients undergoing cytoreductive nephrectomy. Materials and Methods: Using an institutional database we reviewed the records of patients who underwent percutaneous primary tumor biopsy before cytoreductive nephrectomy. In patients who underwent biopsy elsewhere pathology findings were re-reviewed at our institution. Differences in accuracy based on biopsy technique, imaging modality and biopsy period were determined by chi-square analysis. Results: We identified 166 patients who underwent percutaneous biopsy of the primary tumor before cytoreductive nephrectomy between 1991 and 2007, and had data available for review. Median pathological tumor size was 9.1 cm (range 3 to 32). Median time from biopsy to surgery was 46 days (range 6 to 717). Of 104 patients in whom biopsy was assigned a Fuhrman nuclear grade 33 (31.7%) had the same grade in the nephrectomy specimen, including 74 of 109 (67.9%) when considering only high or low grade. Grade change by more than 2 points was seen in 18 of 104 patients (17.3%). Sarcomatoid features were present in 34 of 166 nephrectomy specimens (20.5%) but only 4 (11.8%) were identified preoperatively. Conclusions: In patients with metastatic renal cell carcinoma percutaneous renal biopsy has poor accuracy to assess Fuhrman nuclear grade or sarcomatoid features. Physicians should use caution when using biopsy data to guide therapy. References 1 : Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. J Clin Oncol2009; 27: 4076. Google Scholar 2 : Fine-needle aspiration of renal masses in adults: analysis of results and diagnostic problems in 108 cases. Diagn Cytopathol1999; 20: 339. Google Scholar 3 : Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J Urol1999; 161: 1470. Link, Google Scholar 4 : Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol2007; 178: 379. Link, Google Scholar 5 : Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol2004; 171: 1802. Link, Google Scholar 6 : Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol2003; 180: 1281. Google Scholar 7 : Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol2007; 178: 1184. Link, Google Scholar 8 : Renal mass biopsy—a renaissance?. J Urol2008; 179: 20. Link, Google Scholar 9 : Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol2002; 20: 2376. Google Scholar 10 : Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology. J Urol2007; 178: 1896. Link, Google Scholar 11 : Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma. J Clin Oncol2008; 26: 127. Google Scholar 12 : Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies. Pathology1999; 31: 185. Google Scholar 13 : Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol2002; 167: 65. Link, Google Scholar 14 : Sarcomatoid renal cell carcinoma: A treatable entity. Cancer1987; 60: 1313. Google Scholar 15 : Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma. J Surg Oncol2007; 95: 317. Google Scholar 16 : Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. J Clin Oncol2009; 27: 235. Google Scholar 17 : Phase II trial of capecitabine and weekly docetaxel in metastatic renal cell carcinoma. Urology2008; 72: 898. Google Scholar 18 : Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine. Anticancer Drugs2008; 19: 431. Google Scholar 19 : Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology2000; 216: 506. Google Scholar 20 : Fine needle aspiration biopsy of renal cell carcinoma: Cytologic parameters and their concordance with histology and flow cytometric data. Acta Cytol1993; 37: 367. Google Scholar © 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byTachibana I, Ferguson E, Mahenthiran A, Natarajan J, Masterson T, Bahler C and Sundaram C (2020) Delaying Cancer Cases in Urology during COVID-19: Review of the LiteratureJournal of Urology, VOL. 204, NO. 5, (926-933), Online publication date: 1-Nov-2020.Abel E, Spiess P, Margulis V, Master V, Mann M, Zargar-Shoshtari K, Borregales L, Sexton W, Patil D, Matin S, Wood C and Karam J (2017) Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor ThrombusJournal of Urology, VOL. 198, NO. 2, (281-288), Online publication date: 1-Aug-2017.Abel E, Heckman J, Hinshaw L, Best S, Lubner M, Jarrard D, Downs T, Nakada S, Lee F, Huang W and Ziemlewicz T (2015) Multi-Quadrant Biopsy Technique Improves Diagnostic Ability in Large Heterogeneous Renal MassesJournal of Urology, VOL. 194, NO. 4, (886-891), Online publication date: 1-Oct-2015.Wang H, Zhu Y, Yao X, Zhang S, Dai B, Zhang H, Shen Y, Wang C and Ye D (2012) External Validation of a Nomogram Using RENAL Nephrometry Score to Predict High Grade Renal Cell CarcinomaJournal of Urology, VOL. 187, NO. 5, (1555-1560), Online publication date: 1-May-2012. Volume 184Issue 5November 2010Page: 1877-1881 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.Keywordsnephrectomyrenal cellkidneycarcinomabiopsyneoplasm metastasisMetricsAuthor Information E. Jason Abel Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author Stephen H. Culp Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author Surena F. Matin Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author Pheroze Tamboli Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author Michael J. Wallace Department of Radiology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author Eric Jonasch Department of Genitourinary Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author Nizar M. Tannir Department of Genitourinary Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author Christopher G. Wood Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W2017505770 created "2016-06-24" @default.
• W2017505770 creator A5003974295 @default.
• W2017505770 creator A5007689146 @default.
• W2017505770 creator A5009068086 @default.
• W2017505770 creator A5017537551 @default.
• W2017505770 creator A5048671546 @default.
• W2017505770 creator A5058115259 @default.
• W2017505770 creator A5085172191 @default.
• W2017505770 creator A5089628178 @default.
• W2017505770 date "2010-11-01" @default.
• W2017505770 modified "2023-10-14" @default.
• W2017505770 title "Percutaneous Biopsy of Primary Tumor in Metastatic Renal Cell Carcinoma to Predict High Risk Pathological Features: Comparison With Nephrectomy Assessment" @default.
• W2017505770 cites W1965732727 @default.
• W2017505770 cites W1994226442 @default.
• W2017505770 cites W2000552872 @default.
• W2017505770 cites W2020012641 @default.
• W2017505770 cites W2039598434 @default.
• W2017505770 cites W2039870513 @default.
• W2017505770 cites W2045297417 @default.
• W2017505770 cites W2045778615 @default.
• W2017505770 cites W2055723398 @default.
• W2017505770 cites W2058403940 @default.
• W2017505770 cites W2061956026 @default.
• W2017505770 cites W2067125441 @default.
• W2017505770 cites W2078375261 @default.
• W2017505770 cites W2080679809 @default.
• W2017505770 cites W2120675192 @default.
• W2017505770 cites W2131444088 @default.
• W2017505770 cites W2143887125 @default.
• W2017505770 cites W2151034538 @default.
• W2017505770 cites W2161797239 @default.
• W2017505770 doi "https://doi.org/10.1016/j.juro.2010.06.105" @default.
• W2017505770 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4809737" @default.
• W2017505770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20850148" @default.
• W2017505770 hasPublicationYear "2010" @default.
• W2017505770 type Work @default.
• W2017505770 sameAs 2017505770 @default.
• W2017505770 citedByCount "62" @default.
• W2017505770 countsByYear W20175057702012 @default.
• W2017505770 countsByYear W20175057702013 @default.
• W2017505770 countsByYear W20175057702014 @default.
• W2017505770 countsByYear W20175057702015 @default.
• W2017505770 countsByYear W20175057702016 @default.
• W2017505770 countsByYear W20175057702017 @default.
• W2017505770 countsByYear W20175057702018 @default.
• W2017505770 countsByYear W20175057702019 @default.
• W2017505770 countsByYear W20175057702020 @default.
• W2017505770 countsByYear W20175057702021 @default.
• W2017505770 countsByYear W20175057702022 @default.
• W2017505770 countsByYear W20175057702023 @default.
• W2017505770 crossrefType "journal-article" @default.
• W2017505770 hasAuthorship W2017505770A5003974295 @default.
• W2017505770 hasAuthorship W2017505770A5007689146 @default.
• W2017505770 hasAuthorship W2017505770A5009068086 @default.
• W2017505770 hasAuthorship W2017505770A5017537551 @default.
• W2017505770 hasAuthorship W2017505770A5048671546 @default.
• W2017505770 hasAuthorship W2017505770A5058115259 @default.
• W2017505770 hasAuthorship W2017505770A5085172191 @default.
• W2017505770 hasAuthorship W2017505770A5089628178 @default.
• W2017505770 hasBestOaLocation W20175057702 @default.
• W2017505770 hasConcept C121608353 @default.
• W2017505770 hasConcept C126322002 @default.
• W2017505770 hasConcept C126838900 @default.
• W2017505770 hasConcept C126894567 @default.
• W2017505770 hasConcept C142724271 @default.
• W2017505770 hasConcept C143998085 @default.
• W2017505770 hasConcept C207886595 @default.
• W2017505770 hasConcept C2775934546 @default.
• W2017505770 hasConcept C2777472916 @default.
• W2017505770 hasConcept C2777546739 @default.
• W2017505770 hasConcept C2779013556 @default.
• W2017505770 hasConcept C2780091579 @default.
• W2017505770 hasConcept C2780227381 @default.
• W2017505770 hasConcept C2780283643 @default.
• W2017505770 hasConcept C2780813298 @default.
• W2017505770 hasConcept C2994093513 @default.
• W2017505770 hasConcept C71924100 @default.
• W2017505770 hasConceptScore W2017505770C121608353 @default.
• W2017505770 hasConceptScore W2017505770C126322002 @default.
• W2017505770 hasConceptScore W2017505770C126838900 @default.
• W2017505770 hasConceptScore W2017505770C126894567 @default.
• W2017505770 hasConceptScore W2017505770C142724271 @default.
• W2017505770 hasConceptScore W2017505770C143998085 @default.
• W2017505770 hasConceptScore W2017505770C207886595 @default.
• W2017505770 hasConceptScore W2017505770C2775934546 @default.
• W2017505770 hasConceptScore W2017505770C2777472916 @default.
• W2017505770 hasConceptScore W2017505770C2777546739 @default.
• W2017505770 hasConceptScore W2017505770C2779013556 @default.
• W2017505770 hasConceptScore W2017505770C2780091579 @default.
• W2017505770 hasConceptScore W2017505770C2780227381 @default.
• W2017505770 hasConceptScore W2017505770C2780283643 @default.
• W2017505770 hasConceptScore W2017505770C2780813298 @default.
• W2017505770 hasConceptScore W2017505770C2994093513 @default.
• W2017505770 hasConceptScore W2017505770C71924100 @default.
• W2017505770 hasIssue "5" @default.
• W2017505770 hasLocation W20175057701 @default.
• W2017505770 hasLocation W20175057702 @default.

• next